A Phase I Study of MEDI9447 (Oleclumab) in Japanese Patients

NCT03736473 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Malignancies

Interventions

DRUG: MEDI9447 (oleclumab)

Sponsor

AstraZeneca